Administration ofhuman growth hormone (HGH)
is an effective way of making some very short children grow. The supply of the hormone is inevitably restricted, however, so it is important to try to select correctly those children who will most benefit from the treatment.
The differential diagnosis of children with short stature presents considerable difficulty when stunted growth is not associated with a gross structural abnormality, such as a craniopharyngioma, in the hypothalamico-pituitary region. In the absence of such a lesion, it is hard to distinguish small normal children, or those simply with retarded growth, from those with hormonal inadequacy due to failure of hypothalamic releasing factors or failure in the anterior lobe of the pituitary gland. The situation is further complicated should the birthweight be low.
This paper describes an attempt to differentiate some types of patient who complain of failure to grow. The study extends back over a number of years, and so growth hormone levels are not available on these patients. Classification has been made on clinical and auxological grounds, and the results of laboratory investigations have then been related.
Patients and Their Classification
We have excluded from consideration here all children with known pituitary or brain lesions, or with metabolic or chromosomal disorders. The remainder total 55. They have been divided into three categories entirely on clinical and auxological grounds, with particular reference where possible to the manner in which the child grew in the years following initial testing (summarized in Tables I-III Received September 12, 1966. below). The biochemical findings have not been used to assist in classification.
The three categories are: (1) small normal children (21 children); (2) low birthweight dwarfs (9 children); (3) hyposomatotrophic dwarfs (25 children).
These categories are certainly not to be regarded as immutable divisions, at least at this stage of our knowledge. But they are a useful device for handling our data, and the classification of each individual patient represents a crucial problem. The patients are listed in Tables I, II, and III below. Small normal. When a child was not very far below the 3rd centile for height and gradually and spontaneously caught up towards it as growth proceeded, we classified him as a small normal, particularly if one or both parents were very small. No. 1.17 (Table I) , for instance, was 4 0 standard deviations less than average height at age 9 * 7 years, but her parents and grandparents were all remarkably small. Her predicted adult height was 150 cm. (59 in.) which was at the same centile level as the average of her father and her two grandfathers, and only slightly below the centile level of her mother and her two grandmothers; hence we classified her as small normal. Two children with low birthweights, Nos. 1.9 and 1.15, who subsequently reached the 3rd centile, were included amongst the small normals.
Low birthweight dwarfs. In the low birthweight (LBW) dwarf category we placed children who were well below the 3rd centile for height and whose birthweight was below 2 0 kg. (41 lb.) as suggested by Warkany, Monroe, and Sutherland (1961) and Black (1961) . We have included 4 Mason and Tanner, 1967 (Tanner and Whitehouse, 1967) . At the limit the differentiation between this category and that of Eczcma, asthma, hayfever syndrome Age 4-9, bone age 3-7, ht. (Table I) amongst the small normals is 3 probably one of these, as was his father. No. 1.21 is another, who had her menarche at 19-2 and will eventually reach the third centile. No. 1.19 is a third: he was 3-5 standard deviations below the mean height at age 13 * 8 when he was first seen, and his bone age was 4-3 years retarded; but without treatment he reached the 3rd centile at 15 9 and the 8th centile at 17-7 years.
Another difficulty is provided by children with gonadal dysgenesis associated with a chromosome mosaic. These may have a normal buccal smear;
we eliminated two such patients only in the last draft of this paper. The first was seen at age 16b6, had a bone age of 11 0 (unusually retarded for gonadal dysgenesis), was insulin one-plus sensitive, and had an ACTH response below normal. At age 20 * 9 she had no secondary sex development or menarche. Her karyotype was XO/XX. The (1958) , with the child stretched to the maximum height by gentle traction under the mastoid processes. Conventionally, small children are identified by reference to their centile position on the normal standards, those below the 3rd centile being regarded as small. But a different system has to be used for showing how far below the 3rd centile very small children are, since the location of the 1st and lower centiles is not accurately known. Hence we have calculated a 'height SD score' for each child: this simply represents the number of standard deviations the child is below the mean height for children of his age. This is a convenient but arbitrary measure.
A statistical interpretation cannot be put on the score; for example, a score of 4 0 does not mean that 0 * 0032% of healthy children are smaller than this. The distribution of height at each year of age is not sufficiently perfect in its normality for this to be true, nor is the estimate of the standard deviation at each age sufficiently precise. The SD scores corresponding to the 1st, 3rd, and 10th centiles are approximately 2 * 3, 1 -9, and 1 * 3. The standards used for the means and SDs were those of Tanner, Whitehouse, and Takaishi (1966) .
Weig,oht was taken in the nude.
Skinfolds over triceps and under scapula were measured by one of us (R.H.W.) using the Harpenden skinfold calipers. Centile positions were read by reference to standards for London children (Tanner and Whitehouse, 1962) .
(b) Biochemical. Plasma electrolytes, blood urea, blood sugar, and serum cholesterol on heel or fingerprick blood were determined by standard microprocedures (Wilkinson, 1960) . Plasma calcium was determined with an Eppendorf flame photometer.
Anterior pituitary function was assessed by the following tests. (1) Insulin sensitivity by the method of Daniel (1941) , using half the standard dose, i.e. 0-125 units soluble insulin/kg. body weight. The blood sugar was estimated at 20, 40, 60, and 120 minutes after the subcutaneous injection of the insulin. If the blood sugar dropped by more than 15% from the pre-insulin level and the drop was sustained throughout the 2 hours, or if hypoglycaemic symptoms developed so that the test had to be terminated, this has been recorded as + + in Table I . If, after initially dropping 15%, the blood sugar rose again by 5 mg. at 2 hours or before, compared with its lowest value, the response has been recorded as + in Table I. (2) Serum protein-bound iodine (PBI) on venous blood, was determined by the method of Grossmann and Grossman (1955) . (Normal range 3-3 to 7-5 iLg./100 ml. in our age range.) (3) If the PBI was low, the thyroid uptake of 1321I was measured at varying intervals after 5 mc 1321 given orally. If the uptake was low it was repeated after three days' stimulation with thyrotrophic hormone (5 units daily intramuscularly, Armour Laboratories Ltd.).
(4) The adrenocorticotrophic hormone (ACTH) stimulation test was performed by the method of Clayton, Edwards, and Renwick (1963) . On the day of peak excretion (2nd or 3rd day on ACTH) normal children excrete an average of 32 mg. total 17-hydroxycorticoids, with a lower limit of 20 mg./24 hr. The total output during three days' stimulation with ACTH averages 71 mg. with a lower limit of 37 mg.
Results
In Tables I, II , and III are recorded a number of auxological and biochemical measurements, some further clinical details, and the course of the child's growth from the time of the first examination up to the present or to the last time seen. In each of the three diagnostic groups the children are arranged in ascending order of chronological age, given in column 3. Sex is given in column 2; chronological age at the time of investigation in column 3; and bone age at this time in column 4.
The retardation of bone age is shown in column 5 by chronological age less bone age, and in column 6 by the ratio bone age/chronological age. These two columns give essentially the same information but the ratio is probably better for comparing the degree of retardation of older and younger children.
Height and height SD score are given in columns 7 and 8; weight in column 9. Skinfold centiles are in column 10; the first figure here represents the skinfold measured over the triceps and the second that measured below the angle of the scapula. Comparison of three groups. The proportions of boys to girls are 13: 8 for small normals, 2: 7 for low birthweight dwarfs, and 15: 10 for hyposomatotrophic dwarfs. Possibly the excess of girls amongst the LBW dwarfs is indicative of something of aetiological interest, but it may be due simply to sampling error.
The major results of comparing the 3 groups are given in Table IV where the means and ranges of a number of variables are shown.
Bone age. Bone age was on average more retarded in the hyposomatotrophic dwarfs than in the normals or the LBWs, as can be seen from the second and third rows. The average retardation in the hyposomatotrophic dwarfs was 2 * 7 years, in the small normals 1 * 9 years, and in the LBWs 1 * 3 years. The average ratios were 57% chronological age, 710%, and 75%. The ranges show an almost complete overlap between the groups, but are a little deceptive. It turns out that a ratio of 65% divides fairly well the dwarfs from the small normals. Only 3 of the 25 dwarfs had a bone age less retarded than this, and only 5 of the 21 normals had a bone age more retarded. The 3 exceptional dwarfs may constitute a special group. Two of them (3.17 and 3.25) have been treated with HGH and both had a Height SD score. In height SD score, as expected from our method of classification, the hyposomatotrophic dwarfs are much greater than the other two groups; their mean is 5 * 2 against the small normals mean of 2 7 and the LBW dwarf mean of 3 * 7. There is little overlap between small normals and hyposomatotrophic dwarfs; only 4 of the small normals had SD scores greater than 3-5 when first seen, and three of these a year or more later had changed to less than 3-5. On the other hand, 22 of the 25 hyposomatotrophic dwarfs had scores greater than 3 -5, and on follow-up 2 of the 3 exceptions had changed to greater than 3 * 5. Thus, smallness to a degree that persistently gave an SD score greater than 3* 5 caused us to place the child nearly always in the hyposomatotrophic dwarf category; conversely, children we ultimately felt were really small normals seldom had scores greater than 3 -5. The LBW dwarfs overlapped both other categories; 4 out of 9 had scores below 3-5.
Skinfolds. All three groups contain both very thin and very fat members. But the hyposomatotrophic dwarfs are on average distinctly fatter than the small normals or LBW dwarfs. Whether this represents a physiological result of lack of growth hormone or only a brave attempt on the part of parents to increase calorie input to the maximum is not certain. The former seems more likely however, since two of us have found, in treating these cases with HGH, that children who respond well are fatter than those who respond badly, and that a good initial height response is usually accompanied by an initial fall of skinfolds (Tanner and Whitehouse, 1967) .
Length of gestation and pregnancy conditions. There is little to distinguish the hyposomatotrophic dwarfs from the normals in length of gestation or the incidence of abnormal pregnancy: the LBWs, naturally, have more abnormal pregnancies. Three of the hyposomatotrophic dwarfs were adopted, which seems a high proportion.
Birthweight. Naturally the average birthweight of the LBW dwarfs is much below that of the others. It is interesting, however, that both the other categories have an average birthweight which is a little below the population mean. Prader, Illig, Szeky, and Wagner (1964), Trygstad (1965) , and Wright, Brasel, Aceto, Finkelstein, Kenny, Spaulding, and Blizzard (1965 Growth hormone assays have been made on some of our patients and are in progress on others. We hope they will throw further light on a still confused situation, but we doubt that they will supply more than a partial answer. At present the best simple guide to the diagnosis of the growth hormonelacking child seems to be the growth curve of height, which is much depressed from soon after birth, combined with a very delayed bone age in the absence of hypothyroidism. Summary Fifty-five children suffering from short stature but without known metabolic, chromosomal, or gross nervous system defects have been classified as small normal children (21), low birthweight dwarfs (9), and hyposomatotrophic dwarfs (25) . The classification was made by reference to clinical criteria, growth progress over several years, and, in some cases, a positive response to human growth hormone administration. On these criteria,small normals and hyposomatotrophic (or presumed growth hormone-lacking) dwarfs can best be diagnosed at initial interview by (a) a height which is 3 *5 standard deviations or more below the mean for the child's chronological age, combined with (b) a bone age on the Tanner-Whitehouse standards which is 65% or less of the chronological age.
A subcutaneous insulin sensitivity test, if normal, tends to rule out the diagnosis of hyposomatotrophic dwarfism, but if positive is not very significant, in that a considerable number of small normal children appear to be sensitive. The response to ACTH is without value for distinguishing the two categories.
